Richard I. Fisher, MD, to Join Fox Chase Cancer Center and Temple University School of Medicine


Get Permission

On March 1, 2013, leading cancer center administrator and nationally recognized hematology/oncology expert Richard I. Fisher, MD, will assume leadership roles at Fox Chase Cancer Center, a member of the Temple University Health System, and Temple University School of Medicine, Philadelphia.

Currently, Dr. Fisher is Vice President for Strategic and Program Development at the University of Rochester Medical Center, where he is also the Samuel E. Durand Professor of Medicine. For the past 11 years, Dr. Fisher has served as Director of the James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry and Director of Cancer Services for the Strong Health System in Rochester, New York.

New Responsibilities

At Fox Chase Cancer Center, Dr. Fisher will become Executive Vice President, reporting directly to the President and CEO. He will also be Physician-in-Chief, responsible for overseeing and leading the seven clinical department chairs at the Center. Additionally, Dr. Fisher will be one of two Deputy Directors of Fox Chase’s Cancer Center Support Grant, which supports the Center’s status as 1 of 41 National Cancer Institute–designated Comprehensive Cancer Centers in the nation. At Temple University School of Medicine, Fisher will be Senior Associate Dean for Cancer Programs, reporting to the Dean of the School of Medicine.

“All of us at Fox Chase Cancer Center welcome Richard Fisher to our leadership team and look forward to the additional momentum his extraordinary capabilities as a cancer center administrator, clinician, and researcher will bring to our efforts to prevail over cancer,” said Michael V. Seiden, MD, PhD, President and CEO of Fox Chase Cancer Center.

“I am thrilled to be joining the leadership team at Fox Chase and Temple,” said Dr. Fisher. “As one of the original NCI-designated Cancer Centers, Fox Chase has a tremendous history of contributions to the fight against cancer. Now it will become a model for incorporation of a previously independent cancer center into Temple’s modern, comprehensive health system.” ■



Advertisement

Advertisement



Advertisement